According to Hanmi Pharmaceutical 's latest financial reports the company's current revenue (TTM) is $0.92 B. In 2022 the company made a revenue of $0.80 B a decrease over the years 2021 revenue that were of $0.81 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.92 B | 13.91% |
2022 | $0.80 B | -1.29% |
2021 | $0.81 B | 11.3% |
2020 | $0.73 B | 4.69% |
2019 | $0.70 B | 9.14% |
2018 | $0.64 B | 10.31% |
2017 | $0.58 B | 0.7% |
2016 | $0.57 B | -14.02% |
2015 | $0.67 B | 33.7% |
2014 | $0.50 B | 148.65% |
2013 | $0.20 B | 1027.07% |
2012 | $17.98 M |